Sino Biopharmaceutical Ltd1177:HKG

9.52
0.23 / 2.36 %
9.66m
48.98%
0.3777
Close in HKDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 27 2015 08:59 BST.

Summary

On Monday, Sino Biopharmaceutical Ltd (1177:HKG) closed at 9.52, 11.52 % below its 52-week high of 10.76, set on Apr 09, 2015.

52-week range
Today
5.73
Apr 29 2014
10.76
Apr 09 2015
Markit short selling activity
Low
Medium
High
Open9.60
Day high9.85
Day low9.49
Bid9.50
Offer9.56
Previous close9.75
Average volume14.93m
Shares outstanding4.94bn
Free float2.79bn
P/E (TTM)31.84
Market cap48.18bn HKD
EPS (TTM)0.3062 HKD
Annual div (IAD)0.065 HKD
Annual div yield (IAD)0.67%
Div ex-dateDec 02 2014
Div pay-dateDec 18 2014
Next div ex-dateJun 09 2015
Next div pay-dateJun 24 2015
Data delayed at least 15 minutes, as of Apr 27 2015 08:59 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sino Biopharmaceutical Ltd+5.19 %+26.76 %+22.05 %+48.98 %+175.14 %
HANG SENG INDEX+4.94 %+16.12 %+22.86 %+27.94 %+33.73 %
CN/HEALTH CARE+2.88 %+16.44 %+11.51 %+23.76 %+3.45 %
CHINA A/HEALTH CARE+5.48 %+13.27 %+35.41 %+43.39 %+42.32 %
Data delayed at least 15 minutes, as of Apr 27 2015 08:59 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.